HSPD1 and neoplasm: The similarity between the epitopes of Hsp60 and the SARS-CoV-2 S-protein may not only induce an autoimmune response but also stimulate an anti-tumor immune response [64], analogously to what has been proposed for Hsp60 during Chlamydia trachomatis infection [6].